Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI:AII in older subjects

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 12, 1997, Pages 3513-3518

  Tilly Kiesi, Marju ^c   Lichtenstein, Alice H ^a   Joven, Jorge ^d   Vilella, Elisabet ^d   Cheung, Marian C ^e   Carrasco, Wanda V ^a   Ordovas, Jose M ^a   Dolnikowski, Gregary ^b   Schaefer, Ernst J ^a,b  

^a Lipid Metabolism Laboratory

^b TUFTS UNIVERSITY   (United States)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^e Northwest Lipid Research Laboratories   (United States)

Author keywords

Kinetics; Lipoproteins; LpAI; LpAI:AII; Sex

Indexed keywords

APOLIPOPROTEIN A1; CARBOHYDRATE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEUCINE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; PROTEIN; SATURATED FATTY ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HUMAN; HUMAN EXPERIMENT; IMMUNOAFFINITY CHROMATOGRAPHY; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; POSTMENOPAUSE; PRIORITY JOURNAL; SECRETION; ULTRACENTRIFUGATION;

EID: 0031443761     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.12.3513     Document Type: Article

References (19)

1. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR, Bangdiwala S, Tyroler HF. High density lipoprotein cholesterol and cardiovascular disease, four prospective American studies. Circulation. 1989;79:5-15.
2. Cheung MC, Albers JJ. Distribution of high density lipoprotein particles with different apolipoprotein composition: particles with A-I and A-II and particles with A-I but no A-II. J Lipid Res. 1982;23:747-753.
3. Atmeh RF, Shepherd J, Packard CI. Subpopulations of apolipoprotein A-I in human high-density lipoproteins, their metabolic properties and response to drug therapy. Biochim Biophys Acta. 1983;75:175-188.
4. Cheung M, Albers JJ. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. J Biol Chem. 1984;259:12201-12209.
5. Puchois P, Kandoussi A, Fievet P, Fourrier JL, Bertland M, Koren E, Fruchart JC. Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis. 1987;68:35-40.
6. Parra HJ, Arveiler D, Evans AE, Cambou JP, Amouyel P, Bingham A, McMaster D, Schaffer P, Douste-Blazy P, Luc G. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb. 1992;12:701-707.
7. Coste-Burel M, Mainard F, Chivot L, Auget JL, Madec Y. Study of lipoprotein particles LpAI and LpAIAII in patients before coronary bypass surgery. Clin Chem. 1990;36:1889-1891.
8. Genest JJ, Bard JM, Fruchart JC, Ordovas JM, Wilson PWF, Schaefer EJ. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease. Atherosclerosis. 1991;90:149-157.
9. Ohta T, Hattori S, Murakami M, Nishiyama S, Matsuda I. Age- and sex-related differences in lipoproteins containing apolipoprotein A-I. Arteriosclerosis. 1989;9:90-95.
10. Williams PT, Vranizan KM, Austin MA, Krauss RM. Associations of age, adiposity, alcohol intake, menstrual status, and estrogen therapy with high-density lipoprotein subclasses. Arterioscler Thromb. 1993;13:1654-1661.
11. Li Z, McNamara JR, Fruhart J-C, Luc G, Bard JM, Ordovas JM, Wilson PWF, Schaefer EI. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. J Lipid Res. 1996;37:1886-1896.
12. Schaefer EJ, Lamon-Fava S, Ordovas JM, Cohn SD, Schaefer MM, Castelli WP, Wilson PWF. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res. 1994;35:871-882.
13. Lamon-Fava S, Jenner JL, Jacques PF, Schaefer EJ. Effects of dietary intakes on plasma lipids, lipoproteins. and apolipoproteins in freeliving elderly men and women. Am J Clin Nutr. 1994;59:32-41.
14. Witteman JCM, Grobbee DE, Kok FJ, Hoffman A, Valkenburg HA. Increased risk of atherosclerosis in women after the menopause. Br Med J. 1989;298:642-644.
15. Ikewaki K, Zech LA, Kindt M, Brewer HB Jr, Rader DJ. Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans. Arterioscler Thromb Vasc Biol. 1995;15:306-312.
16. Duverger N, Rader D, Brewer HB Jr. Distribution of subclasses of HDL containing apoA-I without apoA-II (LpA-I) in normolipidemic men and women. Arterioscler Thromb. 1994;14:1594-1599.
17. Schaefer EJ, Zech LA, Jenkins LL, Bronzert TJ, Rubalcaba EA, Lindgren FT, Aamodt RL, Brewer HB Jr. Human apolipoprotein A-I and A-II metabolism. J Lipid Res. 1982;23:850-862.
18. Brinton EA, Eisenberg S, Breslow JL. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. J Clin Invest. 1989;84:262-269.
19. Brinton EA, Eisenberg S, Breslow JL. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein upases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb. 1994;14:707-720.